MMP-2/MMP-9

Class

Matrix metalloproteinase inhibitor

MMP-2 and MMP-9, known as gelatinases, are zinc-dependent enzymes that degrade components of the extracellular matrix, the structural scaffold surrounding cells, particularly type IV collagen and gelatin found in basement membranes. These membranes form barriers that normally confine cells within tissue compartments. Under physiological conditions, gelatinases participate in tissue remodeling, wound repair, and immune cell trafficking. In disease, their activity becomes dysregulated: tumor cells exploit gelatinase activity to breach basement membranes and invade surrounding tissue and blood vessels, a step required for metastasis. Elevated gelatinase activity also contributes to vascular remodeling in atherosclerosis and aneurysm formation, and to tissue destruction in chronic inflammatory and fibrotic conditions. Because MMP-2 and MMP-9 share overlapping substrates and are frequently co-expressed at sites of active tissue remodeling, inhibiting both together addresses functional redundancy that a single-target agent might not fully cover. Small-molecule inhibitors are designed to block the catalytic zinc-binding site these enzymes share, restraining matrix breakdown. This mechanism has been explored across oncology, where limiting invasion and angiogenesis is the goal, and in cardiovascular and fibrotic diseases, where excessive matrix turnover drives pathological remodeling.